Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin D3 pseudogene 2 (CCND3P2) is a human pseudogene—it is a non-coding genetic element similar in sequence to the functional cyclin D3 (CCND3) gene but does not encode a functional protein. Pseudogenes are remnants of genes that have lost their protein-coding ability or are no longer expressed in the cell. As such, CCND3P2 does not have a recognized role as a therapeutic target, does not encode a protein with biological function, and is not associated with disease mechanisms, drug interactions, or biomarker status[2]. Misidentification or confusion may occur between CCND3P2 and the functional CCND3 gene, which encodes the G1/S-specific cyclin-D3, a cell cycle regulator[1][6].\n\nKey clarification:\nCCND3P2 is not a protein, not a receptor, not a functional gene product, and has no established role in disease or therapy. If the intent is to target cyclin D3 itself, then "Cyclin D3" (CCND3) should be used instead. CCND3P2 should not be used as a therapeutic target or biomarker name[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin D3 pseudogene 2 (CCND3P2).